1. Home
  2. RNAC vs NRIM Comparison

RNAC vs NRIM Comparison

Compare RNAC & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAC
  • NRIM
  • Stock Information
  • Founded
  • RNAC 2007
  • NRIM 1990
  • Country
  • RNAC United States
  • NRIM United States
  • Employees
  • RNAC N/A
  • NRIM N/A
  • Industry
  • RNAC Biotechnology: Pharmaceutical Preparations
  • NRIM Savings Institutions
  • Sector
  • RNAC Health Care
  • NRIM Finance
  • Exchange
  • RNAC Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • RNAC 428.2M
  • NRIM 474.2M
  • IPO Year
  • RNAC 2016
  • NRIM N/A
  • Fundamental
  • Price
  • RNAC $19.29
  • NRIM $78.44
  • Analyst Decision
  • RNAC Strong Buy
  • NRIM
  • Analyst Count
  • RNAC 8
  • NRIM 0
  • Target Price
  • RNAC $41.67
  • NRIM N/A
  • AVG Volume (30 Days)
  • RNAC 136.8K
  • NRIM 66.2K
  • Earning Date
  • RNAC 03-06-2025
  • NRIM 01-27-2025
  • Dividend Yield
  • RNAC N/A
  • NRIM 3.14%
  • EPS Growth
  • RNAC N/A
  • NRIM 22.45
  • EPS
  • RNAC N/A
  • NRIM 5.86
  • Revenue
  • RNAC $47,938,000.00
  • NRIM $141,590,000.00
  • Revenue This Year
  • RNAC $56.02
  • NRIM N/A
  • Revenue Next Year
  • RNAC N/A
  • NRIM $5.97
  • P/E Ratio
  • RNAC N/A
  • NRIM $13.38
  • Revenue Growth
  • RNAC N/A
  • NRIM 12.70
  • 52 Week Low
  • RNAC $11.67
  • NRIM $43.92
  • 52 Week High
  • RNAC $41.87
  • NRIM $91.72
  • Technical
  • Relative Strength Index (RSI)
  • RNAC 53.24
  • NRIM 51.22
  • Support Level
  • RNAC $18.27
  • NRIM $68.90
  • Resistance Level
  • RNAC $20.12
  • NRIM $78.80
  • Average True Range (ATR)
  • RNAC 1.25
  • NRIM 2.70
  • MACD
  • RNAC 0.20
  • NRIM 0.25
  • Stochastic Oscillator
  • RNAC 77.69
  • NRIM 85.56

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.

Share on Social Networks: